Venkatesh Srinivasan

This profile gathers the share dealings of Venkatesh Srinivasan in Sutro Biopharma, Inc. Between 1 March 2024 and 1 May 2025, the trades on record add up to 13 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 5 May 2025, reports a share grant of €847 in Sutro Biopharma, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.